Description
Nilosigna 200 mg capsules contain Nilotinib, a tyrosine kinase inhibitor used to treat Philadelphia.
chromosome-positive Nilosigna 200 mg  in pakistan chronic myeloid leukemia (Ph+ CML). It acts as an antineoplastic agent to inhibit cancer cell growth.
The capsules are typically light yellow opaque hard gelatin, Nilosigna 200 mg capsule online containing 200 mg of Nilotinib as hydrochloride Nilosigna 200 mg capsule price in pakistan monohydrate.
Treatment of Ph+ CML, particularly for newly diagnosed patients or those resistant/intolerant to prior therapy.
Nilotinib 200MG per capsule.Classification: Tyrosine Kinase Inhibitor (TKI).Physical properties: They are usually hard gelatin capsules, and they contain white to yellowish powder.Clinical effects.
This drug acts by inhibiting the enzyme BCR-ABL which leads to the production of too many abnormal white blood cells by the bone marrow, thus stopping or slowing down the progress of cancerous cells.
Food restrictions: Should be taken without any food. At least 2 hours before taking the drug and 1 hour after taking the drug.No food consumption is allowed.Food intake.
The capsules should be taken whole with enough water; opening, crushing, or chewing of the capsules is highly prohibited.Avoidance: Avoid foods like grapefruit, and grapefruit juice because of their high content of CYP3A4 inhibitors that may lead to excessive concentrations of the drug.
Nilotinib is used for the treatment of chronic myelogenous leukaemia. It is classified as a kinase inhibitor. Nilotinib blocks the function of the abnormal protein that promotes the development of cancer cells and thus prevents its spread.
The nilotinib dose for adult patients is 230 mg/m2 twice daily, rounded to the nearest 50 mg dose up to a maximum single dose of 400 mg (refer Table 1 below). Combinations.
